Clinical Trial Update: A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE) [Phase 2]

View source ↗

Summary

A Phase 2 study is evaluating Afimetoran versus placebo in active systemic lupus erythematosus, with the trial currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Afimetoran (Afimetoran)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Systemic Lupus Erythematosus | Phase 2 | Status: ACTIVE_NOT_RECRUITING